ClassID:

20927

A61K38/1738 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals Calcium binding proteins, e.g. calmodulin

Recent Application in this class:
#1
20260069658
2026-03-12

Engineered Ligand promotes TREM1-dependent anti-tumor immunity through cross-presentation

#2
20250000944
2025-01-02

USE OF RECOMBINANT CALRETICULIN IN HAIR GROWTH, HAIR BREEDING, HAIR PROTECTION OR ANTI-HAIR LOSS AND RELATED PRODUCT

#3
20240309399
2024-09-19

METHODS AND COMPOSITIONS FOR ADMINISTERING OTOFERLIN DUAL VECTOR SYSTEMS

#4
20240307488
2024-09-19

ANNEXIN TO INHIBIT BACTERIA

#5
20240148908
2024-05-09

Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies

#6
20230277623
2023-09-07

Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)

#7
20220370554
2022-11-24

Calreticulin for Treating or Preventing an Angiogenic Eye Disease

#8
20220125881
2022-04-28

Method for preparing a bone protein preparation and a bone protein preparation

#9
20220072159
2022-03-10

COMPOSITIONS AND METHODS FOR EXPRESSION OF MULTIPLE BIOLOGICALLY ACTIVE POLYPEPTIDES FROM A SINGLE VECTOR FOR TREATMENT OF CARDIAC CONDITIONS AND OTHER PATHOLOGIES

#10
20210393739
2021-12-23

Therapeutic and cosmetic uses and applications of calreticulin

#11
20210330744
2021-10-28

Methods and Compositions for Treating Neurodegeneration and Fibrosis

#12
20210290727
2021-09-23

MODULATION OF mTORCI ACTIVITY AND AUTOPHAGY VIA CIB2-RHEB INTERACTION

#13
20210275636
2021-09-09

Compositions containing exosome carrying NF-κB inhibitors and methods of using thereof

#14
20210213101
2021-07-15

Compositions for Controlling Neuronal Outgrowth

#15
20210196795
2021-07-01

THERAPEUTIC USE OF VEGF-C AND CCBE1

#16
20210169979
2021-06-10

SYSTEM AND METHOD FOR SONOSENSITIZED CANCER IMMUNOTHERAPY WITH NANOPARTICLES

#17
20210052700
2021-02-25

Method for treating pulmonary fibrosis using S100A3 protein

#18
20210052699
2021-02-25

Pharmaceutical composition for preventing or treating dentin-dental pulp diseases or periodontal disease including CPNE4 protein

#19
20210030894
2021-02-04

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DOMINANTLY-INHERITED CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

#20
20200289617
2020-09-17

Method for preparing a bone protein preparation and a bone protein preparation

#21
20200289616
2020-09-17

Human cancer cell metastasis inhibitory agent and human cancer cell determination agent

#22
20200239862
2020-07-30

Pharmaceutical composition for prevention or treatment of heart failure

#23
20200216561
2020-07-09

Methods and materials for treating cancer

#24
20200108120
2020-04-09

METHOD FOR TREATING PULMONARY FIBROSIS USING S100A3 PROTEIN

#25
20200061155
2020-02-27

COMPOSITIONS AND METHODS FOR TREATING LYNX2 DISORDERS

#26
20200038483
2020-02-06

MATERIAL FOR TREATMENT OF BRAIN INJURY, METHOD FOR TREATMENT OF BRAIN INJURY, MATERIAL FOR REGENERATION OF BRAIN NEURONS, AND METHOD FOR REGENERATION OF BRAIN NEURONS

#27
20190374605
2019-12-12

S100A8/S100A9-induced immunotolerance in newborn subjects

#28
20190343923
2019-11-14

Therapeutic and cosmetic uses and applications of calreticulin

#29
20190290728
2019-09-26

METHODS RELATED TO BREAKING T CELL EXHAUSTION

#30
20180360992
2018-12-20

Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies

#31
20180086803
2018-03-29

Engineered calmodulin for treatment of ryanopathies

#32
20170226170
2017-08-10

Calbindin and BH3 domain chimeric proteins and methods for use

#33
20170218086
2017-08-03

Methods and materials for treating cancer

#34
20160354438
2016-12-08

Therapeutic and cosmetic uses and applications of calreticulin

#35
20160194406
2016-07-07

Modulation of efferocytosis pathways for treatment of atherosclerotic disease

#36
20160193298
2016-07-07

THERAPEUTIC USE OF VEGF-C AND CCBE1

#37
20160038571
2016-02-11

Method and compositions for treatment of calcineurin-related diseases

#38
20150202265
2015-07-23

Method for preparing a bone protein preparation and a bone protein preparation

#39
20150133387
2015-05-14

Modulation of Synaptogenesis

#40
20150086510
2015-03-26

S100 FAMILY PROTEINS AND THEIR USES

#41
20140147423
2014-05-29

PHARMACEUTICAL COMPOSITION CONTAINING FIBULIN-3 PROTEIN AS AN ACTIVE INGREDIENT FOR INHIBITING THE GROWTH OF CANCER STEM CELLS

#42
20140128322
2014-05-08

Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy

#43
20130288971
2013-10-31

Short peptides for enhancing muscle function

#44
20130150285
2013-06-13

Therapeutic and cosmetic uses and applications of calreticulin

#45
20130123188
2013-05-16

Methods for diagnosing and treating alzheimer's disease (AD) using the molecules that stabilize intracellular calcium (Ca) release

#46
20120115249
2012-05-10

Biomarker for treating cancer patients

#47
20120065122
2012-03-15

Pharmaceutical Composition and Method for Modulating Slow Myosin

#48
20110256100
2011-10-20

SECRETED MODULAR CALCIUM BINDING PROTEIN FOR INTRACELLULAR MODULATION OF BONE MORPHOGENETIC PROTEIN SIGNALING

#49
20100098732
2010-04-22

METHODS, PROCESSES AND COMPOSITIONS COMPRISING THE PROTEIN CALMODULIN (CAM) FOR TREATMENT OF DAMAGED OR AGING SKIN, AND/OR HAIR LOSS

#50
20090156496
2009-06-18

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING PERIPHERAL NERVE DAMAGE

#51
20090123565
2009-05-14

Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto

#52
20090074754
2009-03-19

Methods and compositions useful in the treatment of mucositis

#53
20090029920
2009-01-29

Methods and compositions for treating ocular disorders

#54
20090029909
2009-01-29

Modulation of synaptogenesis

#55
20070232523
2007-10-04

Therapeutic compositions of oncomodulin

#56
20060210647
2006-09-21

Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto

#57
20060104967
2006-05-18

Method of converting the state of proteins

#58
20050064409
2005-03-24

CHP for use as marker for sepsis-type inflammatory diseases

#59
20050059594
2005-03-17

Methods and compositions for producing a neurosalutary effect in a subject

#60
20050054558
2005-03-10

Methods and compositions for treating ocular disorders

#61
14512867
2016-01-05

Methods for treating microbial infection